Global Biologics Safety Testing Market by Product (Consumable, Instruments, Services), Test Type (Bioburden Tests, Endotoxin Tests, Mycoplasma Tests), Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Biologics Safety Testing Market by Product (Consumable, Instruments, Services), Test Type (Bioburden Tests, Endotoxin Tests, Mycoplasma Tests), Application, End-User - Forecast 2024-2030

Report
181 Pages
June 2024
Region: Global
360iResearch™
ID: 4989657

UP TO €671EUR$697USD£570GBP OFF until Dec 31^st 2024

The Biologics Safety Testing Market grew from USD 5.62 billion in 2023 to USD 6.43 billion in 2024. It is expected to continue growing at a CAGR of 14.71%, reaching USD 14.70 billion by 2030.

The increased need for safety monitoring & testing in clinical trial activities, along with the growing focus on medical device evaluation, is expanding the adoption of biologics safety testing systems and services. The growing number of drug recalls and government initiatives and standards for biologics product safety are the major drivers for product penetration. However, the high-cost requirement of safety testing for the development of drugs and the limited availability of skilled professionals to perform accurate testing impedes proper testing activities. Technological innovation and advancements in biologics safety testing can assist in addressing operational factors and serve users with cost-effective products. Ongoing research for improved safety recombinant protein and cell & gene therapy is expected to proliferate the development of new customized testing services.

Regional Insights

The biologics safety testing market considering the Americas region, particularly in the United States, is well-established and highly regulated, fostering a robust demand for safety testing to ensure compliance with stringent FDA guidelines. This includes tests for contamination, potency, and purity of biological products. Moving to EMEA, Europe leads in market maturity similar to the Americas with strong regulatory frameworks provided by agencies such as the EMA (European Medicines Agency). The market is driven by advanced healthcare infrastructures and heightened awareness regarding biological safety. The Asia Pacific region showcases rapid growth in the biologics safety testing market, which is stimulated by increasing investments in biotechnology sectors, rising pharmaceutical outsourcing, and enhancements in healthcare infrastructures, particularly in countries including China and India. Overall, the global perspective on biologics safety testing underlines a convergence towards higher regulatory scrutiny, technological advancements in testing, and an expanded focus on ensuring the safety of biologic products across all regions.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Biologics Safety Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Exponential need for safety monitoring & testing in clinical trials activities
Growing number of drug recalls and government initiatives and standards for biologics product safety
Increasing production and trade of medical devices and their quality evaluation

Market Restraints

High-cost requirement of safety testing for the development of drugs

Market Opportunities

Technological innovation and advancements in biologic safety testing
Expanding research for improved safety recombinant protein and cell & gene therapy

Market Challenges

Lack of skilled professionals to perform accurate testing

Market Segmentation Analysis

Product: Cruciality of services for biopharmaceutical companies to navigate the complex regulatory landscapes
Application: Increasing adoption in vaccine & therapeutics development to validate the effectiveness and safety of vaccines and new therapeutic drugs

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biologics Safety Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biologics Safety Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Oxford Nanopore Technologies and PathoQuest Collaborate on Groundbreaking Biopharmaceutical Safety Test

Oxford Nanopore and PathoQuest in collaboration released GMP-accredited nanopore-based biologics genetic characterization test, takes safety testing of biologics to the next level, providing a new level of confidence in the safety and efficacy of biologics. The collaboration combines Oxford Nanopore's technology prowess with PathoQuest's expertise in biologics safety to create an innovative solution that stands to have a significant impact in the biopharmaceutical industry. This is a significant milestone for both companies as it heralds a new era in biologics safety testing.

Expanding Biologics Production: A Strategic Look at Teva's Ulm Facility and Future Plans

Teva is significantly increasing its investment in biologics production, with a keen focus on biosimilars and novel biologic products. The central hub of this expansion is Teva's Ulm facility in Germany, which represents a substantial investment exceeding one billion US dollars aimed at amplifying in-house manufacturing capabilities and improving supply reliability. Bioreactors, a critical component in the biotech production process, play an essential role at this site. These vessels facilitate the growth and product production of genetically modified cells under optimal conditions, controlling for factors such as temperature, pH, and oxygen levels.

Expansion of Clean Cells Advances Biopharmaceutical Testing Capabilities in Europe

Clean Cells launched a new biopharmaceutical quality testing service offering vital safety testing for biologics, ensuring that pharmaceutical products are free of contaminants and meet the highest safety standards. As the biologics market continues to expand, the demand for testing services has also increased, and Clean Cells is committed to delivering unparalleled quality and expertise to the industry. Backed by over 25 years of experience in the field, Clean Cells is uniquely positioned to provide comprehensive and reliable biopharmaceutical quality testing. With this newest offering, the company is poised to further solidify its reputation as a trusted partner for the biologics industry.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biologics Safety Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biologics Safety Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Agilent Technologies, Inc., Almac Group Limited, Associates of Cape Cod, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, BSL Bioservice Scientific Laboratories Munich GmbH, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Eagle Analytical Services, Eurofins Scientific Limited, F. Hoffmann-La Roche Ltd., FUJIFILM Wako Pure Chemical Corporation, Laboratory Corporation of America Holdings, Lonza Group AG, Maravai Lifesciences, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sterigenics International LLC, Pacific BioLabs by Northview Biosciences, Inc., Promega Corporation, PromoCell GmbH, QIAGEN GmbH, Rockland Immunochemicals, Inc., Samsung Biologics, Sartorius AG, SGS S.A., SGS Société Générale de Surveillance SA, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Biologics Safety Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Consumable
Instruments
Services

Test Type

Bioburden Tests
Endotoxin Tests
Mycoplasma Tests
Residual Host-Cell Proteins & DNA Detection Tests
Sterility Tests
Virus Safety Tests

Application

Blood & Blood-Related Products Development
Cellular & Gene Therapy Products Development
Monoclonal Antibodies Development
Vaccine & Therapeutics Development

End-User

Academic & Research Institutes
Contract Research Organization/ Contract Manufacturing Organization
Pharmaceutical & Biotechnology Companies

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Exponential need for safety monitoring & testing in clinical trials activities
5.1.1.2. Growing number of drug recalls and government initiatives and standards for biologics product safety
5.1.1.3. Increasing production and trade of medical devices and their quality evaluation
5.1.2. Restraints
5.1.2.1. High-cost requirement of safety testing for the development of drugs
5.1.3. Opportunities
5.1.3.1. Technological innovation and advancements in biologic safety testing
5.1.3.2. Expanding research for improved safety recombinant protein and cell & gene therapy
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals to perform accurate testing
5.2. Market Segmentation Analysis
5.2.1. Product: Cruciality of services for biopharmaceutical companies to navigate the complex regulatory landscapes
5.2.2. Application: Increasing adoption in vaccine & therapeutics development to validate the effectiveness and safety of vaccines and new therapeutic drugs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Biologics Safety Testing Market, by Product

6.1. Introduction
6.2. Consumable
6.3. Instruments
6.4. Services

7. Biologics Safety Testing Market, by Test Type

7.1. Introduction
7.2. Bioburden Tests
7.3. Endotoxin Tests
7.4. Mycoplasma Tests
7.5. Residual Host-Cell Proteins & DNA Detection Tests
7.6. Sterility Tests
7.7. Virus Safety Tests

8. Biologics Safety Testing Market, by Application

8.1. Introduction
8.2. Blood & Blood-Related Products Development
8.3. Cellular & Gene Therapy Products Development
8.4. Monoclonal Antibodies Development
8.5. Vaccine & Therapeutics Development

9. Biologics Safety Testing Market, by End-User

9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organization/ Contract Manufacturing Organization
9.4. Pharmaceutical & Biotechnology Companies

10. Americas Biologics Safety Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biologics Safety Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biologics Safety Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Oxford Nanopore Technologies and PathoQuest Collaborate on Groundbreaking Biopharmaceutical Safety Test
13.3.2. Expanding Biologics Production: A Strategic Look at Teva's Ulm Facility and Future Plans
13.3.3. Expansion of Clean Cells Advances Biopharmaceutical Testing Capabilities in Europe
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio

List of Figures

FIGURE 1. BIOLOGICS SAFETY TESTING MARKET RESEARCH PROCESS
FIGURE 2. BIOLOGICS SAFETY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOLOGICS SAFETY TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BIOLOGICS SAFETY TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. BIOLOGICS SAFETY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. BIOLOGICS SAFETY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONSUMABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MYCOPLASMA TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MYCOPLASMA TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST-CELL PROTEINS & DNA DETECTION TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VIRUS SAFETY TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VIRUS SAFETY TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD & BLOOD-RELATED PRODUCTS DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD & BLOOD-RELATED PRODUCTS DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODIES DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY MONOCLONAL ANTIBODIES DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 76. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 77. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 80. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 81. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 82. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 83. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 84. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 85. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 117. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 118. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 119. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 120. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 121. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 128. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 129. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 132. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 142. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 143. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 144. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 145. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 189. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 190. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 191. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 192. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 193. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 215. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 218. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 219. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. DENMARK BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 226. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 227. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. EGYPT BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 232. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 233. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 234. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 235. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. FINLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 242. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 243. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 250. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 251. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 254. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 266. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 267. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 287. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 290. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 291. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. NORWAY BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 298. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 299. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. POLAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 304. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 305. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 306. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 307. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 310. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 326. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 334. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TAB

Companies Mentioned

Accugen Laboratories, Inc.
Agilent Technologies, Inc.
Almac Group Limited
Associates of Cape Cod, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
bioMérieux SA
BSL Bioservice Scientific Laboratories Munich GmbH
Charles River Laboratories International, Inc.
Creative Biolabs, Inc.
Eagle Analytical Services
Eurofins Scientific Limited
F. Hoffmann-La Roche Ltd.
FUJIFILM Wako Pure Chemical Corporation
Laboratory Corporation of America Holdings
Lonza Group AG
Maravai Lifesciences
Merck KGaA
Microcoat Biotechnologie GmbH
Nelson Laboratories, LLC by Sterigenics International LLC
Pacific BioLabs by Northview Biosciences, Inc.
Promega Corporation
PromoCell GmbH
QIAGEN GmbH
Rockland Immunochemicals, Inc.
Samsung Biologics
Sartorius AG
SGS S.A.
SGS Société Générale de Surveillance SA
Thermo Fisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 6.43 Billion
Forecasted Market Value ( USD ) by 2030	$ 14.7 Billion
Compound Annual Growth Rate	14.7%
Regions Covered	Global
No. of Companies Mentioned	30

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3412EUR$3,545USD£2,899GBP €3791EUR$3,939USD£3,221GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4287EUR$4,454USD£3,643GBP €4764EUR$4,949USD£4,047GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€6037EUR$6,272USD£5,129GBP €6708EUR$6,969USD£5,699GBP